Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.92
Delayed Data
As of Feb 27
 -0.05 / -2.54%
Today’s Change
1.71
Today|||52-Week Range
5.30
+4.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
AssetsShort Term Investment Cash-45.4M-8.9M25.0M34.4M
 
 
 
 
 
Cash & Short Term Investments36.1M27.2M52.0M86.4M
 
 
 
 
 
 
ReceivablesReceivables8.7M4.8M1.4M2.1M
 
 
 
 
 
 
InventoriesInventories1.2M279.0K4.0M8.0M
 
 
 
 
 
 
Current AssetsPrepaid Expenses354.0K235.0K251.0K286.0K
 
 
 
 
 
Other Current Assets0.000.003.3M1.2M
 
 
 
Current Assets46.3M32.5M61.1M97.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross25.0M29.4M31.1M32.0M
 
 
 
 
 
Depreciation-7.6M-11.1M-14.8M-18.3M
 
 
 
 
 
Other Assets942.0K1.0M1.3M1.7M
 
 
 
 
 
Total Assets64.7M51.8M78.7M113.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable6.3M5.0M5.3M5.3M
 
 
 
 
 
Accrued Expenses5.6M3.9M6.2M4.9M
 
 
 
 
 
Other Current Liabilities10.2M11.3M18.7M19.9M
 
 
 
 
 
Other Liabilities18.9M18.7M25.8M26.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.000.0067.0M
 
 
Other Liabilities0.006.6M5.4M2.4M
 
 
 
 
Total Liabilities76.1M77.9M82.1M140.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-11.3M-26.1M-3.4M-26.9M
 
 
 
 
 
Total Shareholder Equity-11.3M-26.1M-3.4M-26.9M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding81.2M85.6M93.5M93.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account